Related references
Note: Only part of the references are listed.ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
Jun Hong et al.
CANCER RESEARCH (2013)
An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2013)
The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
J. D. Paccez et al.
ONCOGENE (2013)
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
Clint E. Johnson et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers
Flip H. Jansen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Targeting Axl With an High-affinity Inhibitory Aptamer
Laura Cerchia et al.
MOLECULAR THERAPY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL
A. E. Sayan et al.
ONCOGENE (2012)
PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells
Giridhar Mudduluru et al.
BIOLOGY OF THE CELL (2011)
Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells
Romain Gioia et al.
BLOOD (2011)
Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer
Chen-Yun Yeh et al.
BMC CANCER (2011)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma
Xianzhou Song et al.
CANCER (2011)
Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
Elvira Avilla et al.
CANCER RESEARCH (2011)
Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase
Marialuisa Sensi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation
Yisheng Jiao et al.
MOLECULAR CANCER (2011)
Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
Kathryn Tworkoski et al.
MOLECULAR CANCER RESEARCH (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
M. Z. Xu et al.
ONCOGENE (2011)
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
K. Vuoriluoto et al.
ONCOGENE (2011)
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G. Mudduluru et al.
ONCOGENE (2011)
MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer
Jih-Hsiang Lee et al.
PLOS ONE (2011)
Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors
Alexis Mollard et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Mechanisms of AXL overexpression and function in Imatinibresistant chronic myeloid leukemia cells
Maeva Dufies et al.
ONCOTARGET (2011)
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma
Ren Liu et al.
BLOOD (2010)
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma
Hector Alvarez et al.
CANCER BIOLOGY & THERAPY (2010)
Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
Fei Huang et al.
CANCER RESEARCH (2010)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer
Giridhar Mudduluru et al.
MOLECULAR CANCER RESEARCH (2010)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Differential Expression of Axl in Hepatocellular Carcinoma and Correlation With Tumor Lymphatic Metastasis
Ling He et al.
MOLECULAR CARCINOGENESIS (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Jan-Bart M. Koorstra et al.
CANCER BIOLOGY & THERAPY (2009)
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu et al.
CANCER RESEARCH (2009)
How epigenetics can explain human metastasis A new role for microRNAs
Amaia Lujambio et al.
CELL CYCLE (2009)
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
Anna Gustafsson et al.
CLINICAL CANCER RESEARCH (2009)
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Todd M. Morgan et al.
CLINICAL CANCER RESEARCH (2009)
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors
Sebastien Grosso et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells
P. Gamas et al.
LEUKEMIA (2009)
Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
Anna Gustafsson et al.
PLOS ONE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
AXL is a potential target for therapeutic intervention in breast cancer progression
Yi-Xiang Zhang et al.
CANCER RESEARCH (2008)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system
A. E. Erson et al.
CLINICAL GENETICS (2008)
OncomiRs: the discovery and progress of microRNAs in cancers
William C. S. Cho
MOLECULAR CANCER (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors
D. Mahadevan et al.
ONCOGENE (2007)
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinorna cells expressing AXL
Jong-Ding Lay et al.
CANCER RESEARCH (2007)
Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: Identification of SKS-927
Diane H. Boschelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy
Kevin T. Nash et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway
Tateo Sawabu et al.
MOLECULAR CARCINOGENESIS (2007)
A developmental view of microRNA function
Yong Zhao et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases
Sassan Hafizi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
J. Green et al.
BRITISH JOURNAL OF CANCER (2006)
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
P Vajkoczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Drug discovery in the kinase inhibitory field using the Nested Chemical Library™ technology
G Kéri et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
K Macleod et al.
CANCER RESEARCH (2005)
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor
PP Sainaghi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein
DL Carlone et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival
PR van Ginkel et al.
CANCER RESEARCH (2004)
Acetylated Sp3 is a transcriptional activator
S Ammanamanchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of the proto-oncogene Axl in renal cell carcinoma
BI Chung et al.
DNA AND CELL BIOLOGY (2003)
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21Cip1 promoter
WG Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers
WS Sun et al.
ANNALS OF ONCOLOGY (2003)
Biological properties and gene expression associated with metastatic potential of human osteosarcoma
T Nakano et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma
WS Sun et al.
MOLECULAR HUMAN REPRODUCTION (2003)
Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around Chernobyl
M Ito et al.
THYROID (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
CpG binding protein is crucial for early embryonic development
DL Carlone et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion
A Wimmel et al.
EUROPEAN JOURNAL OF CANCER (2001)
Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast
G Berclaz et al.
ANNALS OF ONCOLOGY (2001)
Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles
DH Boschelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Sp3 is a transcriptional repressor of transforming growth factor-β receptors
S Ammanamanchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
A Angelillo-Scherrer et al.
NATURE MEDICINE (2001)
The protein tyrosine kinase family of the human genome
DR Robinson et al.
ONCOGENE (2000)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Cutting edge:: A novel function for the SLAP-130/FYB adapter protein in β1 integrin signaling and T lymphocyte migration
AJ Hunter et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
